Categories Therapeutic area -Adelphi Values Provision of regulatory support for use of the Pictorial Blood Loss Assessment Chart (PBAC) in women’s health Development of an ePRO for adult and adolescent dysmenorrhea Regulatory consultation on dysmenorrhea assessments for an FDA type C meeting Endpoint strategy in dysmenorrhea Local market adaption of economic models for 2nd line mesothelioma treatment Consultancy and training on a shortness of breath claim in mesothelioma Understanding and documenting the disease burden of metachromatic leukodystrophy Support of patient survey study development among patients with metachromatic leukodystrophy Web-based survey implementation and analytic consulting support in metachromatic leukodystrophy Clinical outcome assessment strategy development and validation in metachromatic leukodystrophy Pre-screen interviews for the relative resource utilisation of intravenous and subcutaneous drug administration in metastatic bone disease Research to validate and investigate the relative resource utilisation of intravenous and subcutaneous drug administration in metastatic bone disease Literature review of cardiovascular disease in migraine patients Systematic literature review in migraine Development of a PRO measure in chronic adolescent migraine Statistical analysis plan for in-trial psychometric validation of the assessment of chronic migraine symptoms and impacts measures Gap analysis and assessment of PROs in migraine Development of a PRO measure in postdrome migraine Development of an FDA briefing document and regulatory support in chronic migraine Qualitative interviews in chronic migraine headaches Gap analysis of PRO measures in paediatric migraine Generation of evidence for the content validity of instruments assessing motor weakness in hemiplegic migraine Review of concussion PROs relating to migraine Meta-analysis of a treatment for recurrent miscarriage PRO questionnaire development in mitochondrial myopathy Cognitive debriefing interviews for the Primary Mitochondrial Disease (PMD) Symptom Assessment Questionnaire Understanding the experience of the mucopolysaccharidosis I (MPS I) patient to improve outcome assessments: evidence from the literature and treatment experts Cognitive debriefing interviews on the Mucopolysaccharidosis Health Assessment Questionnaire (MPS-HAQ) Evaluating the MPS-HAQ for use in patient registries to support EMA regulatory commitments PRO endpoint review in multinodal goiter Cognitive debriefing on quality of life in multinodal goiter Qualitative data analysis and FDA support in multinodal goiter Development of a manuscript on the burden of relapse in multiple myeloma Value dossier for treatment in multiple myeloma Development of a conference poster on multiple myeloma Research strategy and publication plan to support the burden of relapse in multiple myeloma Communication of the findings from patient and physician interviews on the burden of relapse in multiple myeloma Conference poster on the burden of relapse in multiple myeloma Meta-analysis, mixed treatment comparison and multiparameter evidence synthesis of the efficacy of a treatment for multiple myeloma Quality of life analysis of clinical trial data in multiple myeloma Burden of disease deck, payer value dossier deck and frequently asked questions deck in multiple myeloma European survey quantifying the impact of novel treatments on quality of life in multiple myeloma Mixed treatment comparison of a treatment for multiple myeloma Standalone budget impact models in multiple myeloma Analysis of a treatment in multiple myeloma Analysis of PROs in randomised controlled clinical trial in multiple myeloma Statistical analysis of the minimally important differences and responder thresholds in myeloma Sensitivity analysis in myeloma PRO analysis in multiple myeloma PRO analysis of clinical trials on a treatment for multiple myeloma Patient interviews in multiple myeloma Manuscript and publication support on the use of minimal residual disease testing by US physicians who treat patients with multiple myeloma Manuscript on multiple myeloma quality of life trial results Conference presentation of PRO study results in multiple myeloma Poster reporting results from multiple myeloma patient interviews FDA regulatory review on a treatment for multiple myeloma Clinical trial analyses to support HRQoL in multiple melanoma Value dossier and e-v@luate platform for a drug used in the treatment of relapsed/refractory multiple myeloma (RRMM) Global value dossier and e-v@luate platform for a treatment in RRMM Quality of life analysis for treatment of RRMM Quality of life analysis, SAP and reporting for a treatment in RRMM Full analysis and QoL endpoints in RRMM German PRO analysis to support submission of a study on a biological therapy drug used in RRMM Global value dossier update in multiple sclerosis (MS) Multiple technology appraisal in MS for NICE Research into UK data sources for MS Delphi study (with KOL and payer interviews) to inform market access strategy in MS Utility elicitation study on patients with MS Validation of three cost-effectiveness and budget impact models in MS Negotiation of a licensing agreement for the Multiple Sclerosis Impact Scale (MSIS-29) Review and formatting of patient reported resource use, work productivity and caregiver burden in MS Qualitative research to validate a screening tool for secondary progressive MS PRO endpoint review in MS Briefing document, advisory board and labelling strategy for the FDA on a treatment for MS Cognitive debriefing UK study on walking impairment in MS Psychometric testing of walking impairment in MS Manuscript for the development and psychometric assessment of the Early Mobility Impairment Questionnaire (EMIQ) in MS Rasch analysis of the cognitive debriefing survey data collected in a qualitative phase for MS Rasch analysis and report of DSP data collected on the Full Scale Intelligence Quotient (FSIQ) measure in MS PRO instrument reviews in relapsing MS and spinal cord injury PRO review on MS PRO statistical analysis plan for a clarity trial in MS Selection of a PRO for depression in MS Endpoint review of a treatment for MS Concept confirmation and cognitive debriefing of spasticity PRO measures in MS patients, and development of spasticity screener Development and validation of a clinical screening tool for overactive bladder in MS Advisory board for a clinical screening tool for overactive bladder in MS Development of a predictive calculator for a clinician-completed screening tool in secondary progressive multiple sclerosis (SPMS) Psychometric validation of a clinician completed screening tool in SPMS Exploratory analysis of phase II clinical trial data for acute optic neuritis Relapsed-remitting multiple sclerosis Development, content confirmation and validation of a fatigue measure in relapsing-remitting multiple sclerosis (RRMS) Work on the equivalency of an e-PRO on the FSIQ in RRMS Qualitative work in subgroups with RRMS Development of a PRO measurement strategy in relapsing MS Mode of administration equivalency and usability testing of the MSIS-29 in patients with relapsing MS Development of a PRO dossier for the MSIS-29 in RRMS Psychometric validation of a newly developed PRO for patients with RRMS Poster development on the Fatigue Symptom and Impact Questionnaire for Relapsing Multiple Sclerosis (FSIQ-RMS) COA review and development for muscle wasting associated with chronic illness Exit interviews to explore patient disease burden, treatment satisfaction and clinical trial participation in muscle wasting associated with chronic obstructive pulmonary disease (COPD) Qualitative research to support the identification of key impacts on physical functioning and activities of daily living in patients with muscle wasting Conference abstract and poster for early decision modelling in acute pain Strategic literature review of chronic pain Competitive assessment and burden of illness in chronic low back pain Content confirmation and testing of the Roland Morris Disability Questionnaire (RMDQ) and Pain NRS Personal Digital Assistant in chronic low back pain Development of a responder index in low back pain Manuscript on the chronic low back pain responder index Development of a PRO measure of stiffness in acute low back pain Focus group interviews with patients with chronic low back pain Gap analysis and strategic recommendation for PRO and market access studies in chronic low back pain and diabetic peripheral neuropathy Mode of Administration (MOA) equivalency study in lower back pain Consulting on PRO analysis and study design of trials in chronic low back pain Burden, economics, epidemiology and treatment patterns in chronic low back pain Qualitative exit interviews to assess the patient experience of treatment and clinical trial participation among patients with chronic low back pain Gap analysis and review of PRO measures in low back pain and neck pain Development of a briefing document on the modified Brief Pain Inventory – Short Form (mBPI-SF) in acute musculoskeletal pain Critical review of PRO instruments in fatigue and pain in rheumatic disease PRO literature review in pelvic pain Patient perspective literature review for chronic pelvic pain in both men and women Value dossier and e-v@luate platform in a treatment for low-risk myelodysplastic syndrome Value dossier and e-v@luate platform in a treatment for high-risk myelodysplastic syndrome Resource utilisation in myelodysplastic syndromes Quality of life analysis for a treatment in myelodysplastic syndrome Patient survey of the indirect costs and quality of life impacts in myelodysplastic syndromes Qualitative interviews with patients with myelodysplastic syndrome In-trial analyses of treatments in myelodysplastic syndrome (TASTE-PRO) Manuscript support in myelodysplastic syndrome (TASTE-PRO) Global value dossier and e-v@luate platform for a treatment in myelofibrosis Quality of life analysis, value proposition and value messages for a treatment in myelofibrosis Modification of a web-based patient survey to assess QoL, economic impact and work productivity for patients with myeloproliferative neoplasms Development and documentation of a PRO questionnaire for use among patients with myelofibrosis in second line treatment Score interpretation guidance on the use of the Myelofibrosis Symptom Assessment Form (MF-SAF) diary in treatment resistant patients Post-hoc analysis of PRO outcomes in a phase II clinical trial in myeloid metaplasia Literature review of the unmet need in patients with a history of myocardial infarction and high risk of developing atherothrombotic events Literature review of coronary artery bypass grafting (CABG) treatment in acute myocardial infarction (AMI) Validation of clinician and patient questionnaires for myocardial infarction imaging Development and validation of patient and clinician tools for myocardial infarction imaging Analysis and reporting of myocardial infarction imaging validation study data Clinician and patient satisfaction in an observational study in myocardial infarction SPECT imaging Quantitative validation of symptom scores in nasal polyposis Characterisation of symptoms and impacts of severe nasal polyps Manuscripts, abstracts and posters on neural tube defects Top-up literature review and communications on the burden of neural tube defects to patients, carers and society Review on the burden of neural tube defects to healthcare systems, patients, care-givers and society Content validation of a neurogenic detrusor overactivity (NDO) diary in paediatric spina bifida patients Payer value proposition, payer value dossier and cost-effectiveness model in neuroendocrine tumours (NETs) Development of preference, tolerability and satisfaction PROs for patients with neuroendocrine tumours (NETs) Defence of the use of the Orthostatic Hypotension Questionnaire (OHQ) to demonstrate treatment benefit and labelling claim in neurogenic orthostatic hypotension Validation of the OHQ in neurogenic orthostatic hypotension using clinical trial data Key opinion leader interviews on neurogenic orthostatic hypotension Evaluation of the current measurement strategy in neurogenic orthostatic hypotension Cookies Policy